(2) Leading Virtual Diagnostic Tool to Be Offered Network-Wide Pending Pilot Outcome VANCOUVER, BC / ACCESSWIRE / March 10, 2021 / EMPOWER CLINICS INC. (CBDT:CSE) (EPWCF:OTCQB) (8EC:Frankfurt) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens and MedX Health Corporation (TSX-V: MDX) are pleased to announce a Memorandum of Understanding between the companies to pilot MedX's leading-edge DermSecure Screening Platform at two select Empower Clinics locations in Ontario with plans for a broader market roll-out pending the completion of a successful pilot. "Empower exists to make testing, screening and diagnostics as convenient as possible for patients," said Steven McAuley, Chairman and CEO of Empower. "Providing our patients with easy access to quality virtual services like teledermatology compliments our current COVID-19 testing amid the ongoing pandemic. MedX is an ideal teledermatology partner, as their screening platform is second to none. We look forward to the results of this pilot and making the platform more widely available throughout our network."